Finance

Beta
Lists
ICLR:NASDAQ
ICON PLC
$153.25
+0.94%
(+1.43) 1D
Jun 10, 9:36:47 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ICLR...
Open
$152.62
High
$153.35
Low
$150.11
Mkt. cap
11.66B
Avg. vol.
1.27M
Volume
7.00
P/E ratio
52.77
52-wk high
$211.00
52-wk low
$66.57
EPS
$2.90
Beta
1.26
Shares outstanding
76.57M
No. of employees
40K
Open
$152.62
High
$153.35
Low
$150.11
Mkt. cap
11.66B
Avg. vol.
1.27M
Volume
7.00
P/E ratio
52.77
52-wk high
$211.00
52-wk low
$66.57
EPS
$2.90
Beta
1.26
Shares outstanding
76.57M
No. of employees
40K
Analyst outlook
Analyst Ratings
Based on 13 analysts giving stock ratings to ICLR in the past 3 months
Buy
Buy
6
Hold
6
Sell
1
12 month forecast
Based on 13 Wall Street analysts offering 12 month price targets for ICLR in the last 3 months.
Highest
Current $153.25
$180.00 (+17.46%)
Average
$147.55 (-3.72%)
Lowest
$125.00 (-18.43%)
News stories
From sources across the web
Profile
Icon plc is an Irish headquartered multinational healthcare intelligence and clinical research organisation. As of February 2025 had approximately 41,900 employees in 55 countries. Wikipedia
About ICON PLC
CEOBarry Balfe
Employees40.1K
Founded1990
Headquarters-
SectorHealth care
Awaiting results...
Call Time: Wed, May 27, 4:00 PM
Fiscal period
Q1 2026
EPS / Est. (USD)
- / $2.43
Revenue / Est. (USD)
- / 2.00B
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
2.00B
2.02B
2.04B
2.19B
Cost of goods sold
1.44B
1.46B
1.49B
1.69B
Cost of revenue
1.44B
1.46B
1.49B
1.69B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
199.88M
205.01M
198.75M
181.20M
Operating expense
295.84M
302.72M
297.24M
272.02M
Total operating expenses
1.74B
1.76B
1.78B
1.96B
Operating income
264.31M
258.88M
258.90M
230.37M
Other non operating income
-
-
-
-
EBT including unusual items
173.75M
161.11M
38.10M
-120.50M
EBT excluding unusual items
218.50M
210.78M
210.42M
182.37M
Income tax expense
19.60M
-21.86M
35.75M
-10.36M
Effective tax rate
11.28%
-13.57%
93.82%
8.60%
Other operating expenses
-
-
-
-
Net income
154.15M
182.97M
2.36M
-110.14M
Net profit margin
7.70%
9.07%
0.12%
-5.03%
Earnings per share
3.19
3.26
3.31
2.52
Interest and investment income
1.80M
2.05M
1.76M
1.49M
Interest expense
-47.61M
-50.15M
-50.24M
-49.49M
Net interest expenses
-45.81M
-48.10M
-48.48M
-48.00M
Depreciation and amortization charges
95.96M
97.72M
98.50M
90.82M
EBITDA
360.27M
356.59M
357.40M
321.19M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more